Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Bloom

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
The Lancet. Infectious Diseases|November 11, 2019
The public health crisis of underimmunisation: a global plan of actionLawrence O Gostin, James G Hodge, Barry R Bloom, et al.
American Journal of Respiratory and Critical Care Medicine|July 11, 2017
High-Dose Vitamin D<sub>3</sub> during Tuberculosis Treatment in Mongolia. A Randomized Controlled TrialDavaasambuu Ganmaa, Baatar Munkhzul, Wafaie Fawzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2008
Immunization by a bacterial aerosolLucila Garcia-Contreras, Yun-Ling Wong, Pavan Muttil, et al.
Science Immunology|September 2, 2018
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteriaSamuel J Balin, Matteo Pellegrini, Eynav Klechevsky, et al.
Nature Medicine|May 10, 2005
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cellsStephan R Krutzik, Belinda Tan, Huiying Li, et al.
Cell|August 26, 2017
A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in LeprosyCressida A Madigan, C J Cambier, Kindra M Kelly-Scumpia, et al.
Journal of Health Communication|July 3, 2019
The Salzburg Statement on Vaccination AcceptanceScott C Ratzan, Barry R Bloom, Ayman El-Mohandes, et al.
Science (New York, N.Y.)|September 13, 2003
Use of genetic profiling in leprosy to discriminate clinical forms of the diseaseJoshua R Bleharski, Huiying Li, Christoph Meinken, et al.
Science Translational Medicine|August 22, 2014
IL-32 is a molecular marker of a host defense network in human tuberculosisDennis Montoya, Megan S Inkeles, Phillip T Liu, et al.
Cell Reports|March 28, 2019
Dual RNA-Seq of Human Leprosy Lesions Identifies Bacterial Determinants Linked to Host Immune ResponseDennis J Montoya, Priscila Andrade, Bruno J A Silva, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
The Lancet. Infectious Diseases|November 11, 2019
The public health crisis of underimmunisation: a global plan of actionLawrence O Gostin, James G Hodge, Barry R Bloom, et al.
American Journal of Respiratory and Critical Care Medicine|July 11, 2017
High-Dose Vitamin D<sub>3</sub> during Tuberculosis Treatment in Mongolia. A Randomized Controlled TrialDavaasambuu Ganmaa, Baatar Munkhzul, Wafaie Fawzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2008
Immunization by a bacterial aerosolLucila Garcia-Contreras, Yun-Ling Wong, Pavan Muttil, et al.
Science Immunology|September 2, 2018
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteriaSamuel J Balin, Matteo Pellegrini, Eynav Klechevsky, et al.
Nature Medicine|May 10, 2005
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cellsStephan R Krutzik, Belinda Tan, Huiying Li, et al.
Cell|August 26, 2017
A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in LeprosyCressida A Madigan, C J Cambier, Kindra M Kelly-Scumpia, et al.
Journal of Health Communication|July 3, 2019
The Salzburg Statement on Vaccination AcceptanceScott C Ratzan, Barry R Bloom, Ayman El-Mohandes, et al.
Science (New York, N.Y.)|September 13, 2003
Use of genetic profiling in leprosy to discriminate clinical forms of the diseaseJoshua R Bleharski, Huiying Li, Christoph Meinken, et al.
Science Translational Medicine|August 22, 2014
IL-32 is a molecular marker of a host defense network in human tuberculosisDennis Montoya, Megan S Inkeles, Phillip T Liu, et al.
Cell Reports|March 28, 2019
Dual RNA-Seq of Human Leprosy Lesions Identifies Bacterial Determinants Linked to Host Immune ResponseDennis J Montoya, Priscila Andrade, Bruno J A Silva, et al.
Pageof 9